TherapeuticsMD TXMD Cash Flow Statement (2010-2026)

NASDAQ TXMD
$1.90 +0.02 (+1.06%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

TherapeuticsMD Quarterly Cash Flow Statement

Periods 65 quarters
Latest Jun 2026

TherapeuticsMD reported cash from operations of $0.78M and free cash flow of $0.78M for the quarter ended Jun 2026, up 104.5% year over year. This cash flow statement covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-47.42M-42.96M-49.02M112.28M-28.97M77.70M-3.60M-2.41M-3.38M-0.88M-0.73M-1.09M-0.61M0.25M-0.65M0.55M0.15M-0.62M0.10M0.16M
Depreciation and DepletionDep. & Depletion
0.20M-0.20M0.10M0.20M0.20M0.20M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
Amortization of Deferred ChargesAmort. Deferred Charges
Depreciation & Amortization (CF)Dep. & Amort.
1.03M-2.36M0.33M0.28M0.27M0.31M0.03M0.13M0.13M0.64M0.13M0.18M0.10M0.10M0.10M0.10M0.10M0.10M0.09M0.10M
Share-based CompensationStock Comp.
7.30M5.33M2.06M2.20M4.30M3.01M0.48M0.44M0.23M0.12M0.11M0.10M0.03M0.02M0.02M0.00M0.05M0.00M0.00M
Cash from Discontinued OperationsCash from Discont. Ops
-31.15M156.02M-7.30M-131.01M-24.47M-1.28M3.57M-2.88M0.24M-0.56M-0.11M-0.01M-0.01M-0.06M0.05M-0.01M-0.01M-0.01M
Gains from Sales and DivestituresGains Divest
143.38M
Asset Writedowns and ImpairmentWritedown
0.06M0.01M1.26M
Other non-cash itemsOther Non-Cash
0.10M-0.01M8.65M0.27M0.15M0.22M0.23M0.23M
Change in Working Capital
Change in ReceivablesChange Receivables
4.02M-1.23M-0.49M11.09M-13.65M
Change in InventoryChange Inventory
0.37M0.26M1.42M-2.82M0.55M
Change in Account PayablesChange Payables
5.03M0.41M-0.50M-0.36M-0.43M0.08M0.16M-0.82M-0.81M-0.67M0.11M0.00M0.09M0.02M-0.08M0.17M-0.09M0.11M-0.34M0.42M
Change in Accured ExpensesChange Accured Exp.
0.56M-8.87M-2.93M2.19M19.08M-14.08M-4.49M-2.88M-4.56M-3.80M-0.41M-0.04M0.14M-0.69M0.27M-0.19M0.43M-0.24M0.43M-0.36M
Change in Other Operating AssetsOther Assets Change
3.20M-1.71M-1.05M10.06M-9.41M7.41M1.47M-2.09M0.67M-0.93M-0.66M-1.13M-0.10M-0.44M-0.94M0.26M-0.53M-1.01M-0.69M-0.48M
Change in Other Operating LiabilitiesOther Liabilities Change
0.40M1.38M-0.26M0.26M-1.11M0.08M0.48M0.08M-0.21M-0.32M-0.16M-0.20M-0.15M-0.21M-0.27M-0.33M-0.27M-0.27M
Other Working Capital ChangesOther WC Changes
-2.80M3.09M1.05M-10.06M9.15M-7.15M-2.58M2.17M-0.19M1.01M0.45M0.82M-0.06M0.24M0.78M-0.46M0.27M0.68M0.42M0.21M
Other Operating ActivitiesOther Ops.
0.29M-0.01M-0.01M-0.01M-0.01M-0.02M-0.06M-0.02M0.60M-0.65M0.19M0.19M0.20M-0.79M0.15M0.22M0.22M
Cash from OperationsCash from Ops.
-38.22M48.00M-17.87M-20.72M17.72M30.24M-8.70M-3.39M-6.03M-4.96M-0.23M1.45M-0.07M0.02M0.70M0.38M1.00M0.38M0.94M0.78M
Investing Activities
Capital ExpendituresCapex
-0.07M0.04M-0.02M
Change in Property, Plant and EquipmentChange in PP&E
0.07M-0.04M0.02M
Change in IntangiblesChange Intangibless
0.25M1.51M0.17M0.10M-0.01M0.10M
Divestments
Net of Acquisitions & DivestmentsNet Acquisitions
Purchase of InvestmentsInvestments Purchased
Other Investing ActivitiesOther investing
-0.13M223.78M
Cash from Investing ActivitiesCash from Investing
-0.18M-1.51M-0.21M-0.08M0.01M-0.07M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
Long-Term Debt RepaymentsLT Debt Repayment
5.00M120.00M94.43M
Non-Current Debt
-5.00M-120.00M-94.43M
Short-Term Debt issuancesST Debt Issuance
Short-Term Debt repaymentsST Debt Repayment
Current Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
-5.00M-120.00M-94.43M
Change in Capital Stock
Common Stock IssuedStock Issued
31.82M1.25M-0.01M0.00M2.00M
Net Shares Issued and RepurchasedNet Shares Issued
31.82M1.25M-0.01M0.00M2.00M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
5.43M
Net Equity Issued and RepurchasedNet Equity Issued
31.82M1.25M5.42M0.00M2.00M
Other financing activitiesOther financing
-0.73M-0.54M1.11M0.00M-1.11M
Cash from Financing ActivitiesCash from Financing
31.82M1.35M-5.00M-120.00M1.74M-111.95M0.00M2.00M
Additional items
Change in Cash
-6.58M-39.72M-34.74M-4.08M12.03M10.99M-32.07M-3.52M-3.56M-5.84M0.01M0.89M-0.19M0.01M0.69M0.32M1.05M0.37M0.94M0.77M
Ending Cash Balance
104.84M64.91M65.12M65.12M65.12M49.32M17.25M49.32M49.32M4.33M4.34M5.06M5.75M6.07M7.48M8.42M9.19M
Free Cash FlowFCF
-38.15M48.00M-17.91M-20.70M17.72M30.24M-8.70M-3.39M-6.03M-4.96M-0.23M1.45M-0.07M0.02M0.70M0.38M1.00M0.38M0.94M0.78M
Net Cash FlowNCF
-6.58M47.84M-23.08M-140.80M19.46M-81.78M-8.70M-3.39M-6.03M-2.96M-0.23M1.45M-0.07M0.02M0.70M0.38M1.00M0.38M0.94M0.78M
Interest Paid
5.39M5.39M5.36M-5.36M8.37M5.17M

TherapeuticsMD Cash Flow Statement API

Pull TherapeuticsMD's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TXMD&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY